GlassScriptPhysician profile
Tayo A Addo
NPI 1457328403
$4,321.85
in general payments reported to CMS, 2019-2025
14 companies · $356 in 2025
The $356 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,832 · 2020: $502 · 2021: $565 · 2022: $367 · 2023: $108 · 2024: $593 · 2025: $356.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,057.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,056.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $1,470.91 | 2019-2021 | |
| Abbott Laboratories | $904.76 | 2019-2024 | Dragonfly Opstar, Diamondback Coronary, Coroflow |
| Boston Scientific Corporation | $399.04 | 2019-2024 | Avvigo Guidance System |
| Bard Peripheral Vascular, INC. | $265.57 | 2022 | |
| Opsens INC. | $256.99 | 2019-2020 | |
| Ge Healthcare | $234.22 | 2025 | |
| Medtronic, INC. | $231.98 | 2021-2024 | Symplicity G3, Onyx Frontier |
| Recor Medical INC | $146.35 | 2024 | Paradise Renal Denervation System |
| Abiomed | $142.16 | 2022-2023 | Impella |
| Abbvie INC. | $112.19 | 2020 | |
| Shockwave Medical, INC | $78.02 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Corcym INC | $30.81 | 2025 | Perceval |
| Lantheus Medical Imaging, INC. | $25.25 | 2025 | |
| Teleflex LLC | $23.60 | 2025 | Trapliner |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tayo Addo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.